Tirzepatide

Tirzepatide

Product Overview

Tirzepatide is a synthetic peptide compound intended strictly for academic, laboratory, and institutional research use only. Tirzepatide is a synthetic 39-amino-acid peptide that acts as a dual agonist for the GIP and GLP-1 receptors. Marketed under the brand names Mounjaro (for Type 2 diabetes) and Zepbound (for chronic weight management), it significantly reduces appetite, improves glycemic control, and promotes substantial weight loss.

Research Use

Tirzepatide is studied in controlled laboratory models for its interaction with metabolic signaling pathways, endocrine communication systems, and receptor-mediated biological activity.

Research Focus Areas

Research commonly focuses on GIP and GLP-1 receptor signaling pathways, intracellular communication mechanisms, peptide stability, formulation integrity, and laboratory handling procedures.

Compliance Information

This product must only be handled by qualified professionals in controlled research environments and in compliance with applicable laws, biosafety standards, and ethical research guidelines.

For research use only. Not for human or animal consumption.